Author Correction: PPP2R1A mutations portend improved survival after cancer immunotherapy

Yibo Dai^#^{1

2}, Anne Knisely^#³, Mitsutake Yano^#⁴, Minghao Dang^#¹, Emily M Hinchcliff⁵, Sanghoon Lee³, Annalyn Welp⁶, Manoj Chelvanambi⁷, Matthew Lastrapes⁷, Heng Liu⁸, Zhe Yuan⁸, Chen Wang⁴, Hao Nie⁴, Stephanie Jean⁹, Luis J Montaner⁸, Jiakai Hou¹⁰, Ami Patel³, Shrina Patel³, Bryan Fellman¹¹, Ying Yuan¹¹, Baohua Sun¹², Renganayaki Krishna Pandurengan¹², Edwin Roger Parra Cuentas¹², Joseph Celestino³, Yan Liu¹³, Jinsong Liu¹³, R Tyler Hillman³, Shannon N Westin³, Anil K Sood³, Pamela T Soliman³, Aaron Shafer³, Larissa A Meyer³, David M Gershenson³, David Vining¹⁴, Dhakshinamoorthy Ganeshan¹⁴, Karen Lu³, Jennifer A Wargo^{1

2

7}, Weiyi Peng¹⁰, Rugang Zhang^{15

16}, Linghua Wang^{17

18

19

20}, Amir A Jazaeri^{21

22}

Affiliations

¹ Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
² The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX, USA.
³ Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁴ Department of Experimental Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁵ Northwestern University, Feinberg School of Medicine, Robert H Lurie Comprehensive Cancer Center, Chicago, IL, USA.
⁶ University of Virginia School of Medicine, Charlottesville, VA, USA.
⁷ Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁸ Immunology, Metastasis and Microenvironment Program, The Wistar Institute, Philadelphia, PA, USA.
⁹ Helen F. Graham Cancer Center & Research Institute, Newark, DE, USA.
¹⁰ Department of Biology & Biochemistry, University of Houston, Houston, TX, USA.
¹¹ Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
¹² Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
¹³ Department of Anatomic Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
¹⁴ Department of Abdominal Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
¹⁵ The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX, USA. RZhang11@mdanderson.org.
¹⁶ Department of Experimental Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. RZhang11@mdanderson.org.
¹⁷ Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. LWang22@mdanderson.org.
¹⁸ The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX, USA. LWang22@mdanderson.org.
¹⁹ The James P. Allison Institute, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. LWang22@mdanderson.org.
²⁰ Institute for Data Science in Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. LWang22@mdanderson.org.
²¹ The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX, USA. aajazaeri@mdanderson.org.
²² Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. aajazaeri@mdanderson.org.

^# Contributed equally.

PMID: 40913056
PMCID: PMC12460151
DOI: 10.1038/s41586-025-09586-8

Published Erratum

Author Correction: PPP2R1A mutations portend improved survival after cancer immunotherapy

Yibo Dai et al. Nature. 2025 Sep.

. 2025 Sep;645(8082):E10.

doi: 10.1038/s41586-025-09586-8.

Authors

Affiliations

¹ Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
² The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX, USA.
³ Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁴ Department of Experimental Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁵ Northwestern University, Feinberg School of Medicine, Robert H Lurie Comprehensive Cancer Center, Chicago, IL, USA.
⁶ University of Virginia School of Medicine, Charlottesville, VA, USA.
⁷ Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁸ Immunology, Metastasis and Microenvironment Program, The Wistar Institute, Philadelphia, PA, USA.
⁹ Helen F. Graham Cancer Center & Research Institute, Newark, DE, USA.
¹⁰ Department of Biology & Biochemistry, University of Houston, Houston, TX, USA.
¹¹ Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
¹² Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
¹³ Department of Anatomic Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
¹⁴ Department of Abdominal Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
¹⁵ The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX, USA. RZhang11@mdanderson.org.
¹⁶ Department of Experimental Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. RZhang11@mdanderson.org.
¹⁷ Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. LWang22@mdanderson.org.
¹⁸ The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX, USA. LWang22@mdanderson.org.
¹⁹ The James P. Allison Institute, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. LWang22@mdanderson.org.
²⁰ Institute for Data Science in Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. LWang22@mdanderson.org.
²¹ The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX, USA. aajazaeri@mdanderson.org.
²² Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. aajazaeri@mdanderson.org.

^# Contributed equally.

PMID: 40913056
PMCID: PMC12460151
DOI: 10.1038/s41586-025-09586-8

No abstract available

PubMed Disclaimer

Erratum for

PPP2R1A mutations portend improved survival after cancer immunotherapy.
Dai Y, Knisely A, Yano M, Dang M, Hinchcliff EM, Lee S, Welp A, Chelvanambi M, Lastrapes M, Liu H, Yuan Z, Wang C, Nie H, Jean S, Montaner LJ, Hou J, Patel A, Patel S, Fellman B, Yuan Y, Sun B, Pandurengan RK, Cuentas ERP, Celestino J, Liu Y, Liu J, Hillman RT, Westin SN, Sood AK, Soliman PT, Shafer A, Meyer LA, Gershenson DM, Vining D, Ganeshan D, Lu K, Wargo JA, Peng W, Zhang R, Wang L, Jazaeri AA. Dai Y, et al. Nature. 2025 Aug;644(8076):537-546. doi: 10.1038/s41586-025-09203-8. Epub 2025 Jul 2. Nature. 2025. PMID: 40604275 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- PubMed Central
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: PPP2R1A mutations portend improved survival after cancer immunotherapy

Affiliations

Author Correction: PPP2R1A mutations portend improved survival after cancer immunotherapy

Authors

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources

Miscellaneous